Skip to content

Biohaven BHVN Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
10M0.0%
ADMA Biologics logo
ADMA BiologicsADMA
10M0.0%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
10M0.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
10M
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's convertible preferred stock authorized shares?
Biohaven (BHVN) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has Biohaven's convertible preferred stock authorized shares changed year-over-year?
Biohaven's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What is the long-term trend for Biohaven's convertible preferred stock authorized shares?
Over 3 years (2022 to 2025), Biohaven's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.